FDA Authorizes Expanded Use for REGEN-COV mAb

The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

Aug 05, 2021 | Guest Author

  • Webinar, COVID-19, Immunization, Maternal, Child, & Adolescent Health

    Webinar: Building Vaccine Confidence for COVID-19 Vaccines in Adolescents

    Join this webinar on Tuesday, June 22, 3:00-4:00 pm ET.

    Jun 03, 2021 | Beth Hess

  • Tools & Resources, COVID-19, Rural Health

    Toolkit to Increase Vaccine Confidence in Rural Areas

    This toolkit features newly developed and culturally tailored materials, including fact sheets and an infographic, from the HHS...

    May 14, 2021 | Beth Hess

  • Webinar, COVID-19

    Webinar: COVID-19 Vaccine Breakthrough Cases

    Join this webinar on May 4, 3:00-4:30 pm ET.

    Apr 26, 2021 | Beth Hess

  • COVID-19

    FDA Authorizes Expanded Use for REGEN-COV mAb

    The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

    Aug 05, 2021 | Guest Author

    Webinar, COVID-19, Immunization, Maternal, Child, & Adolescent Health

    Webinar: Building Vaccine Confidence for COVID-19 Vaccines in Adolescents

    Join this webinar on Tuesday, June 22, 3:00-4:00 pm ET.

    Jun 03, 2021 | Beth Hess

    Tools & Resources, COVID-19, Rural Health

    Toolkit to Increase Vaccine Confidence in Rural Areas

    This toolkit features newly developed and culturally tailored materials, including fact sheets and an infographic, from the HHS COVID-19 public education campaign.

    May 14, 2021 | Beth Hess

    Webinar, COVID-19

    Webinar: COVID-19 Vaccine Breakthrough Cases

    Join this webinar on May 4, 3:00-4:30 pm ET.

    Apr 26, 2021 | Beth Hess

    3 Newsletters1200 1
    Back to Top